144 related articles for article (PubMed ID: 36226863)
1. Pharmacokinetic study on the co-administration of abemaciclib and astragaloside IV in rats.
Sun S; Liu L; Song H; Li H
Pharm Biol; 2022 Dec; 60(1):1944-1948. PubMed ID: 36226863
[TBL] [Abstract][Full Text] [Related]
2. Effects of puerarin on the pharmacokinetics of astragaloside IV in rats and its potential mechanism.
Zhang H; Song J; Dai H; Liu Y; Wang L
Pharm Biol; 2020 Dec; 58(1):328-332. PubMed ID: 32356474
[No Abstract] [Full Text] [Related]
3. The pharmacokinetic study on the interaction between nobiletin and anemarsaponin BII
Zhang J; Fan M; Yu X; Zhang B
Pharm Biol; 2021 Dec; 59(1):1528-1532. PubMed ID: 34726569
[TBL] [Abstract][Full Text] [Related]
4. Effects of astragaloside IV on the pharmacokinetics of omeprazole in rats.
Liu W; Liu G; Liu J
Pharm Biol; 2019 Dec; 57(1):449-452. PubMed ID: 31290355
[No Abstract] [Full Text] [Related]
5. [Inhibitory effects of astragaloside IV on cytochrome P450 enzyme of rat liver microsomes].
Shan W; Zhang Y; Zhu J; Shao Q; Fan X
Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):85-8. PubMed ID: 22741468
[TBL] [Abstract][Full Text] [Related]
6. Influence of astragaloside IV on pharmacokinetics of triptolide in rats and its potential mechanism.
Gao J; Zeng X; Zhao W; Chen D; Liu J; Zhang N; Duan X
Pharm Biol; 2020 Dec; 58(1):253-256. PubMed ID: 32233814
[No Abstract] [Full Text] [Related]
7. Pharmacokinetic Interaction of astragaloside IV with atractylenolide I and prim-O-glucosylcimifugin in male Sprague Dawley rats.
Song J; Zheng SR; Jin Y; Li J
Planta Med; 2014 Feb; 80(2-3):187-92. PubMed ID: 24452462
[TBL] [Abstract][Full Text] [Related]
8. Effects of Astragaloside IV on the Pharmacokinetics of Metoprolol in Rats and its Mechanism.
Shi Z; Jiang J; Zhao D; Xie B; Li Y; Yu C
Curr Drug Metab; 2022; 23(2):131-136. PubMed ID: 35088663
[TBL] [Abstract][Full Text] [Related]
9. Effects of astragaloside IV on the pharmacokinetics of puerarin in rats.
Liu L; Li P; Qiao L; Li X
Xenobiotica; 2019 Oct; 49(10):1173-1177. PubMed ID: 29790819
[No Abstract] [Full Text] [Related]
10. [Effect of intestinal flora changes on pharmacokinetics of astragaloside Ⅳ].
Zhang Y; Yang CJ; Meng Q; Zhang L; Liu L; Zhang X; Yan D
Zhongguo Zhong Yao Za Zhi; 2021 Jun; 46(12):3144-3149. PubMed ID: 34467706
[TBL] [Abstract][Full Text] [Related]
11. Abemaciclib Does Not Have a Clinically Meaningful Effect on Pharmacokinetics of CYP1A2, CYP2C9, CYP2D6, and CYP3A4 Substrates in Patients with Cancer.
Turner PK; Hall SD; Chapman SC; Rehmel JL; Royalty JE; Guo Y; Kulanthaivel P
Drug Metab Dispos; 2020 Sep; 48(9):796-803. PubMed ID: 32581049
[TBL] [Abstract][Full Text] [Related]
12. ABCB1 and ABCG2 limit brain penetration and, together with CYP3A4, total plasma exposure of abemaciclib and its active metabolites.
Martínez-Chávez A; Loos NHC; Lebre MC; Tibben MM; Rosing H; Beijnen JH; Schinkel AH
Pharmacol Res; 2022 Apr; 178():105954. PubMed ID: 34700018
[TBL] [Abstract][Full Text] [Related]
13. Sensitive and selective liquid chromatography-electrospray ionisation-mass spectrometry analysis of astragaloside-IV in rat plasma.
Huang C; Wang G; Li H; Xie H; Sun J; Lv H; Lv T
J Pharm Biomed Anal; 2006 Feb; 40(3):788-93. PubMed ID: 16307859
[TBL] [Abstract][Full Text] [Related]
14. Baicalein inhibits the pharmacokinetics of simvastatin in rats
Meng M; Li X; Zhang X; Sun B
Pharm Biol; 2021 Dec; 59(1):880-883. PubMed ID: 34214011
[TBL] [Abstract][Full Text] [Related]
15. Protective Effects of Astragaloside IV Combined with Budesonide in Bronchitis in Rats by Regulation of Nrf2/Keap1 Pathway.
Zhang Z; Cheng X; Ge D; Wang S; Qi B
Med Sci Monit; 2018 Nov; 24():8481-8488. PubMed ID: 30471087
[TBL] [Abstract][Full Text] [Related]
16. Anti-anxiety and antidepressant-like effects of astragaloside IV and saponins extracted from Astragalus spinosus against the bisphenol A-induced motor and cognitive impairments in a postnatal rat model of schizophrenia.
Abd Elkader HAE; Abdou HM; Khamiss OA; Essawy AE
Environ Sci Pollut Res Int; 2021 Jul; 28(26):35171-35187. PubMed ID: 33666843
[TBL] [Abstract][Full Text] [Related]
17. Predicting Clinical Effects of CYP3A4 Modulators on Abemaciclib and Active Metabolites Exposure Using Physiologically Based Pharmacokinetic Modeling.
Posada MM; Morse BL; Turner PK; Kulanthaivel P; Hall SD; Dickinson GL
J Clin Pharmacol; 2020 Jul; 60(7):915-930. PubMed ID: 32080863
[TBL] [Abstract][Full Text] [Related]
18. Preclinical pharmacokinetics and tissue distribution of a natural cardioprotective agent astragaloside IV in rats and dogs.
Zhang WD; Zhang C; Liu RH; Li HL; Zhang JT; Mao C; Moran S; Chen CL
Life Sci; 2006 Jul; 79(8):808-15. PubMed ID: 16564551
[TBL] [Abstract][Full Text] [Related]
19. Regulation of drug-metabolizing enzymes and efflux transporters by Astragali radix decoction and its main bioactive compounds: Implication for clinical drug-drug interactions.
Zhang G; Ou R; Li F; Wu J; Zheng L; Tong Y; Liu Y; Liu Z; Lu L
J Ethnopharmacol; 2016 Mar; 180():104-13. PubMed ID: 26805467
[TBL] [Abstract][Full Text] [Related]
20. Astragaloside IV alleviates early brain injury following experimental subarachnoid hemorrhage in rats.
Shao A; Guo S; Tu S; Ammar AB; Tang J; Hong Y; Wu H; Zhang J
Int J Med Sci; 2014; 11(10):1073-81. PubMed ID: 25136262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
